Alnylam Pharmaceuticals, Inc. (ALNY)
NASDAQ: ALNY · Real-Time Price · USD
237.10
+0.54 (0.23%)
At close: Aug 28, 2026, 4:00 PM EDT
240.00
+2.90 (1.22%)
After-hours: Aug 28, 2026, 7:30 PM EDT
Alnylam Pharmaceuticals Market Cap
Alnylam Pharmaceuticals has a market cap or net worth of $31.73 billion as of August 28, 2026. Its market cap has decreased by -46.71% in one year.
Market Cap
31.73B
Enterprise Value
31.41B
1-Year Change
-46.71%
Ranking
Category
Stock Price
$237.10
ChartMarket Cap Chart
Since June 1, 2004, Alnylam Pharmaceuticals's market cap has increased from $135.00M to $31.73B, an increase of 23,400.85%. That is a compound annual growth rate of 27.80%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 28, 2026 | 31.73B | -39.61% |
| Dec 31, 2025 | 52.54B | 73.09% |
| Dec 31, 2024 | 30.35B | 26.35% |
| Dec 29, 2023 | 24.02B | -17.84% |
| Dec 30, 2022 | 29.24B | 44.16% |
| Dec 31, 2021 | 20.28B | 34.32% |
| Dec 31, 2020 | 15.10B | 17.60% |
| Dec 31, 2019 | 12.84B | 74.32% |
| Dec 31, 2018 | 7.37B | -37.48% |
| Dec 29, 2017 | 11.78B | 266.69% |
| Dec 30, 2016 | 3.21B | -59.72% |
| Dec 31, 2015 | 7.98B | 6.90% |
| Dec 31, 2014 | 7.46B | 82.96% |
| Dec 31, 2013 | 4.08B | 326.36% |
| Dec 31, 2012 | 956.60M | 174.73% |
| Dec 30, 2011 | 348.20M | -16.32% |
| Dec 31, 2010 | 416.10M | -43.53% |
| Dec 31, 2009 | 736.80M | -28.05% |
| Dec 31, 2008 | 1.02B | -13.48% |
| Dec 31, 2007 | 1.18B | 71.64% |
| Dec 29, 2006 | 689.60M | 94.42% |
| Dec 30, 2005 | 354.70M | 136.47% |
| Dec 31, 2004 | 150.00M | 11.11% |
| Jun 1, 2004 | 135.00M | - |
View and export this data all the way back to 2004. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Moderna | 57.00B |
| Revolution Medicines | 47.40B |
| BeOne Medicines AG | 42.35B |
| Royalty Pharma | 35.60B |
| BioNTech SE | 27.98B |
| Roivant Sciences | 27.14B |
| Insmed | 26.51B |
| Incyte | 25.89B |